{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:34:46Z","timestamp":1788975286539,"version":"build-2803163510"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Osteosarcoma represents the most common principal malignant bone tumor that predominantly appears among teenagers and children. While multimodal treatment methods have greatly evolved with time, survival for recurrent or metastatic disease remains low due to the resistance that accumulates during treatment. Increasing evidence identifies the tumor microenvironment (TME), in particular cancer-associated fibroblasts (CAFs), as playing an important role in imposing immune suppression, enhancing tumor aggressiveness, and mediating resistance toward immunotherapy and chemotherapy. This article gives an overview of the derivation, phenotypic heterogeneity, and mechanisms of action of CAFs during osteosarcoma, such as facilitating immune escape, survival signaling, drug efflux, regulation of genes through exosomes, and inhibiting ferroptosis. Furthermore, we present existing and new treatment methods that are centered on CAFs, such as suppression of the paracrine pathway (e.g., IL-6\/STAT3, TGF-\u03b2), depletion of CAFs lineages by targeting fibroblast activation protein (FAP), and conversion toward tumor-restraining CAFs. Other methods that are gaining popularity are targeting CAFs-releasing exosomes and metabolic liabilities. By shedding light on CAFs-based methods for imposing resistance and trying targeted treatments, this review offers insights into novel therapeutic combinations that can overcome treatment barriers and improve survival outcomes in osteosarcoma regimens.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1668535","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T05:32:29Z","timestamp":1756704749000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Cancer-associated fibroblasts in osteosarcoma: key players in immune escape and targeted therapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Junjie","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Churong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1584450","article-title":"Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.054207","article-title":"Research progress on cancer-associated fibroblasts in osteosarcoma","volume":"33","author":"Feng","year":"2025","journal-title":"OR"},{"key":"B8","doi-asserted-by":"publisher","first-page":"114612","DOI":"10.1016\/j.yexcr.2025.114612","article-title":"Decoding the function of cancer-associated fibroblasts in osteosarcoma: Molecular pathways, therapeutic approaches and prognostic significance","volume":"450","author":"Hsu","year":"2025","journal-title":"Exp Cell Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10+GPR77+ Cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100662","DOI":"10.1016\/j.jbo.2025.100662","article-title":"The METTL3\/TGF-\u03b21 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m6A modification","volume":"51","author":"Qi","year":"2025","journal-title":"J Bone Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"\u00d6hlund","year":"2014","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGF\u03b2 action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14537","article-title":"Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine","volume":"111","author":"Kanzaki","year":"2020","journal-title":"Cancer Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.109169","article-title":"Cancer-associated fibroblast-like cells promote osteosarcoma metastasis by upregulation of phosphoserine aminotransferase 1 and activation of the mTOR\/S6K pathway","volume":"21","author":"Feng","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13592","DOI":"10.1111\/cpr.13592","article-title":"Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: \u201cSingle\u201d vision for \u201cheterogeneous\u201d environment","volume":"57","author":"Zhang","year":"2024","journal-title":"Cell Prolif"},{"key":"B19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2011.363","article-title":"Fusion between cancer cells and myofibroblasts is involved in osteosarcoma","volume":"2","author":"Yu","year":"2011","journal-title":"Oncol Letters"},{"key":"B21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/mc.23188","article-title":"The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses","volume":"59","author":"Westrich","year":"2020","journal-title":"Mol Carcinog"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 Signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.06.006","article-title":"STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma","volume":"325","author":"Tu","year":"2012","journal-title":"Cancer Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.07.011","article-title":"Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model","volume":"96","author":"Pavlou","year":"2019","journal-title":"Acta Biomater"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7150\/thno.73714","article-title":"Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.10.027","article-title":"Metabolic exchanges within tumor microenvironment","volume":"380","author":"Chiarugi","year":"2016","journal-title":"Cancer Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5049-3","article-title":"CAF cellular glycolysis: linking cancer cells with the microenvironment","volume":"37","author":"Roy","year":"2016","journal-title":"Tumour Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.3390\/ijms231911416","article-title":"Chemoresistance-related stem cell signaling in osteosarcoma and its plausible contribution to poor therapeutic response: A discussion that still matters","volume":"23","author":"Martins-Neves","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41420-024-01854-2","article-title":"FSP1 is a predictive biomarker of osteosarcoma cells\u2019 susceptibility to ferroptotic cell death and a potential therapeutic target","volume":"10","author":"Panczyszyn","year":"2024","journal-title":"Cell Death Discov"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7150\/thno.89805","article-title":"Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer","volume":"14","author":"Zhu","year":"2024","journal-title":"Theranostics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13148","article-title":"Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19148","article-title":"Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/path.6384","article-title":"C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter-mediated doxorubicin resistance","volume":"265","author":"Liu","year":"2025","journal-title":"J Pathology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12935-023-03121-3","article-title":"Tumor-derived exosomal linc00881 induces lung fibroblast activation and promotes osteosarcoma lung migration","volume":"23","author":"Chang","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression","volume":"20","author":"Li","year":"2021","journal-title":"Mol Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1158\/2767-9764.CRC-24-0371","article-title":"Osteosarcoma exosome priming of primary human lung fibroblasts induces an immune modulatory and protumorigenic phenotype","volume":"5","author":"Palmer","year":"2025","journal-title":"Cancer Res Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3727\/096504018X15336368805108","article-title":"Exosomal miR-1228 from cancer-associated fibroblasts promotes cell migration and invasion of osteosarcoma by directly targeting SCAI","volume":"27","author":"Wang","year":"2019","journal-title":"OR"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: orchestrating the composition of Malignancy","volume":"30","author":"Gascard","year":"2016","journal-title":"Genes Dev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/cancers13051172","article-title":"Cancer-associated fibroblast-induced resistance to chemotherapy and radiotherapy in gastrointestinal cancers","volume":"13","author":"Ham","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.767939","article-title":"Exploiting the STAT3 nexus in cancer-associated fibroblasts to improve cancer therapy","volume":"12","author":"Allam","year":"2021","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/1568009623666230712095021","article-title":"Tumor microenvironment heterogeneity, potential therapeutic avenues, and emerging therapies","volume":"24","author":"Peng","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"key":"B46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1479-5876-11-187","article-title":"Treatment of Malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells","volume":"11","author":"Schuberth","year":"2013","journal-title":"J Transl Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3892\/ol.2014.1788","article-title":"Impact of fibroblast activation protein on osteosarcoma cell lines in vitro","volume":"7","author":"Ding","year":"2014","journal-title":"Oncol Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8027","article-title":"Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways","volume":"15","author":"Zeng","year":"2018","journal-title":"Oncol Letters"},{"key":"B49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12964-023-01151-y","article-title":"The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-\u03b1 as a novel biomarker in colorectal cancer","volume":"21","author":"Kalaei","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130110","article-title":"Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia","volume":"210","author":"Tran","year":"2013","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1188641","article-title":"Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition","volume":"13","author":"Capobianco","year":"2023","journal-title":"Front Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.621070","article-title":"Determinants and functions of CAFs secretome during cancer progression and therapy","volume":"8","author":"Linares","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/21655979.2022.2161711","article-title":"Extracellular vesicles in tumorigenesis, metastasis, chemotherapy resistance and intercellular communication in osteosarcoma","volume":"14","author":"Liao","year":"2023","journal-title":"Bioengineered"},{"key":"B54","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/biom13030456","article-title":"The roles of exosomes in metastasis of sarcoma: from biomarkers to therapeutic targets","volume":"13","author":"Tan","year":"2023","journal-title":"Biomolecules"},{"key":"B55","doi-asserted-by":"publisher","first-page":"11016","DOI":"10.1111\/jcmm.17024","article-title":"Exosomal miR-21-5p derived from bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion by targeting PIK3R1","volume":"25","author":"Qi","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1031779","article-title":"Ferroptosis in osteosarcoma: A promising future","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.3390\/cancers15092614","article-title":"A quick guide to CAF subtypes in pancreatic cancer","volume":"15","author":"Brichkina","year":"2023","journal-title":"Cancers"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101230","article-title":"Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade","volume":"5","author":"Miyai","year":"2022","journal-title":"Life Sci Alliance"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410918","article-title":"NGR-modified CAF-derived exos targeting tumor vasculature to induce ferroptosis and overcome chemoresistance in osteosarcoma","volume":"12","author":"Du","year":"2025","journal-title":"Adv Sci (Weinh)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1668535\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T05:32:30Z","timestamp":1756704750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1668535\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2025.1668535"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1668535","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"1668535"}}